Brad Margolis’ experience bettering well being care high quality and decreasing prices will drive contributions to firm’s far-reaching impression

TEL AVIV, Israel, March 01, 2022–(BUSINESS WIRE)–MDI Well being, a medical platform that optimizes remedy remedy at scale, introduced at the moment that Brad Margolis, a well being business chief and innovator, has joined the corporate as its Chief Working Officer.

Margolis, previously COO of Altegra Well being (now a part of Change Healthcare) and at present a board member of OrthoFi, has labored inside and on behalf of organizations to efficiently enhance their high quality of care, scale back prices, and enhance administration of value-based packages by way of know-how and intervention platforms. In his position as MDI Well being’s COO, Margolis will oversee all exterior and inner operations and keep accountability for the corporate’s general operational success.

MDI Well being’s proprietary platform allows a holistic method to decreasing dangers of adversarial drug occasions, combining simulation instruments and synthetic intelligence to supply well being care insurers and suppliers optimum particular person remedy remedy at scale, bettering high quality and decreasing prices.

“MDI Well being is on a mission to eradicate pointless prices and avoidable morbidity attributable to medicines. We’re a mission pushed group, and including somebody with Brad’s depth of expertise, who additionally really stands behind that mission, solely reinforces our conviction and talent to create impression at scale,” mentioned Avishai Ben-Tovim, CEO and Co-Founding father of MDI Well being. “Brad’s management and operational experience will allow us to additional speed up our development and set the stage for true scale.”

“MDI Well being has made it potential to enhance the standard of remedy opinions and intervention by way of its synthetic pharmacology intelligence, which takes into consideration particular person information resembling lab outcomes, way of life elements, and polypharmacy data, and does so at scale, saving and bettering the lives of hundreds of thousands,” mentioned Brad Margolis, MDI COO. “I’m excited to contribute to the success and impression of MDI’s know-how, and to assist impression the lives of sufferers all through the well being care continuum.”

Margolis attained a B.A. in Economics from the College of Illinois and an MBA from the Kellogg Graduate College of Administration at Northwestern College. He’ll report back to MDI Well being CEO Avishai Ben-Tovim.

About MDI Well being

MDI Well being was based in 2019 to fight the rising variety of deaths and prices related to adversarial drug occasions. MDI’s end-to-end remedy remedy platform empowers clinicians to supply complete remedy opinions in minutes as an alternative of hours. The answer checks, in actual time, for personalised remedy associated danger occasions, ensures sufferers have the precise medicines they want, and allows well being payers, suppliers and pharmacies to enhance affected person outcomes, remedy security, and hospitalization charges, which collectively value $528B within the US yearly.

View supply model on


Jon Stone
[email protected]